Mousavi S A, Kjeken R, Berg T O, Seglen P O, Berg T, Brech A
Department of Biology, University of Oslo, Norway.
Biochim Biophys Acta. 2001 Feb 9;1510(1-2):243-57. doi: 10.1016/s0005-2736(00)00354-0.
Bafilomycin A(1) (BAF) and concanamycin A (ConcA) are selective inhibitors of the H(+)-ATPases of the vacuolar system. We have examined the effects of these inhibitors on different steps in endocytic pathways in rat hepatocytes, using [(125)I]tyramine-cellobiose-labeled asialoorosomucoid ([(125)I]TC-AOM) and [(125)I]tyramine-cellobiose-labeled bovine serum albumin ([(125)I]TC-BSA) as probes for respectively receptor-mediated endocytosis and pinocytosis (here defined as fluid phase endocytosis). The effects of BAF and ConcA were in principle identical, although ConcA was more effective than BAF. The main findings were as follows. (1) BAF/ConcA reduced the rate of uptake of both [(125)I]TC-AOM and [(125)I]TC-BSA. The reduced uptake of [(125)I]TC-AOM was partly due to a redistribution of the asialoglycoprotein receptors (ASGPR) such that the number of surface receptors was reduced approximately 40% without a change in the total number of receptors. (2) BAF/ConcA at the same time increased retroendocytosis (recycling) of both probes. The increased recycling of the ligand ([(125)I]TC-AOM) is partly a consequence of the enhanced pH in endosomes, which prevents dissociation of ligand. (3) It was furthermore found that the ligand remained bound to the receptor in presence of BAF/ConcA and that the total amount of ligand molecules internalized in BAF/ConcA-treated cells was only slightly in excess of the total number of receptors. These data indicate that reduced pH in endosomes is the prime cause of receptor inactivation and release of ligand in early endosomes. (4) Subcellular fractionation experiments showed that [(125)I]TC-AOM remained in early endosomes, well separated from lysosomes in sucrose gradients. The fluid phase marker, [(125)I]TC-BSA, on the other hand, seemed to reach a later endosome in the BAF/ConcA-treated cells. This organelle coincided with lysosomes in the gradient, but hypotonic medium was found to selectively release a lysosomal enzyme (beta-acetylglucosaminidase), indicating that even [(125)I]TC-BSA remained in a prelysosomal compartment in the BAF/ConcA-treated cells. (5) Electron microscopy using horseradish peroxidase (HRP) as a fluid phase marker verified that BAF/ConcA inhibited transfer of material from late endosomes ('multivesicular bodies'). (6) BAF/ConcA led to accumulation of lactate dehydrogenase (LDH) in autophagic vacuoles, but although the drugs partly inhibited fusion between autophagosomes and lysosomes a number of autolysosomes was formed in the presence of BAF/ConcA. This observation explains the reduced buoyant density of lysosomes (revealed in sucrose density gradients). In conclusion, BAF/ConcA inhibit transfer of endocytosed material from late endosomes to lysosomes, but do not at the same time prevent fusion between autophagosomes and lysosomes.
巴弗洛霉素A(1)(BAF)和 concanamycin A(ConcA)是液泡系统H(+)-ATP酶的选择性抑制剂。我们使用[(125)I]酪胺-纤维二糖标记的去唾液酸糖蛋白([(125)I]TC-AOM)和[(125)I]酪胺-纤维二糖标记的牛血清白蛋白([(125)I]TC-BSA)分别作为受体介导的内吞作用和胞饮作用(这里定义为液相内吞作用)的探针,研究了这些抑制剂对大鼠肝细胞内吞途径不同步骤的影响。虽然ConcA比BAF更有效,但BAF和ConcA的作用原则上是相同的。主要发现如下。(1)BAF/ConcA降低了[(125)I]TC-AOM和[(125)I]TC-BSA的摄取速率。[(125)I]TC-AOM摄取减少部分是由于去唾液酸糖蛋白受体(ASGPR)的重新分布,使得表面受体数量减少约40%,而受体总数不变。(2)BAF/ConcA同时增加了两种探针的逆向内吞作用(再循环)。配体([(125)I]TC-AOM)再循环增加部分是内体pH升高的结果,这阻止了配体的解离。(3)此外还发现,在BAF/ConcA存在的情况下,配体仍与受体结合,并且BAF/ConcA处理的细胞中内化的配体分子总量仅略超过受体总数。这些数据表明,内体pH降低是早期内体中受体失活和配体释放的主要原因。(4)亚细胞分级分离实验表明,[(125)I]TC-AOM保留在早期内体中,在蔗糖梯度中与溶酶体分离良好。另一方面,液相标记物[(125)I]TC-BSA在BAF/ConcA处理的细胞中似乎到达了较晚期的内体。这个细胞器与梯度中的溶酶体重合,但发现低渗介质选择性地释放一种溶酶体酶(β-乙酰氨基葡萄糖苷酶),这表明即使[(125)I]TC-BSA在BAF/ConcA处理的细胞中仍保留在溶酶体前区室中。(5)使用辣根过氧化物酶(HRP)作为液相标记物的电子显微镜证实,BAF/ConcA抑制了物质从晚期内体(“多囊泡体”)的转运。(6)BAF/ConcA导致乳酸脱氢酶(LDH)在自噬泡中积累,但尽管这些药物部分抑制了自噬体与溶酶体之间的融合,但在BAF/ConcA存在的情况下仍形成了一些自溶酶体。这一观察结果解释了溶酶体浮力密度的降低(在蔗糖密度梯度中显示)。总之,BAF/ConcA抑制内吞物质从晚期内体向溶酶体的转运,但同时并不阻止自噬体与溶酶体之间的融合。